20211105-115531-83
To reduce the risk of opioid overdose and death when reentering the community after incarceration, individuals with opioid use disorder who are incarcerated should have access to jail-provided medications for opioid use disorder (MOUD) – methadone, buprenorphine, and naltrexone – and are promptly connected to services in the community upon release. Planning for reentry from jail is challenging under normal circumstances but is even more challenging when people are admitted and released within days.